IPD Group And 2 Other ASX Penny Stocks To Consider

As the Australian market braces for retail sales figures that could impact interest rate expectations, the ASX 200's recent rally is facing potential headwinds. In such fluctuating conditions, investors often look beyond established giants to explore opportunities in lesser-known areas like penny stocks. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still offer intriguing prospects when supported by strong financials.

Advertisement

Top 10 Penny Stocks In Australia

NameShare PriceMarket CapFinancial Health RatingEmbark Early Education (ASX:EVO)A$0.775A$142.2M★★★★☆☆LaserBond (ASX:LBL)A$0.565A$66.23M★★★★★★Austin Engineering (ASX:ANG)A$0.52A$322.48M★★★★★☆SHAPE Australia (ASX:SHA)A$2.88A$238.78M★★★★★★Helloworld Travel (ASX:HLO)A$2.01A$327.26M★★★★★★SKS Technologies Group (ASX:SKS)A$1.59A$242.07M★★★★★★Vita Life Sciences (ASX:VLS)A$1.915A$107.38M★★★★★★Big River Industries (ASX:BRI)A$1.285A$109.71M★★★★★☆IVE Group (ASX:IGL)A$2.08A$322.17M★★★★☆☆Servcorp (ASX:SRV)A$4.93A$486.42M★★★★☆☆

Click here to see the full list of 1,050 stocks from our ASX Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

IPD Group (ASX:IPG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: IPD Group Limited is an Australian company that distributes electrical infrastructure, with a market cap of A$407.52 million.

Operations: The company generates revenue through its Products Division, contributing A$270.68 million, and its Services Division, which accounts for A$19.74 million.

Market Cap: A$407.52M

IPD Group Limited, with a market cap of A$407.52 million, has shown robust earnings growth, averaging 35.8% annually over five years and accelerating to 39.1% last year, outpacing the industry average. The company maintains high-quality earnings and its debt is well covered by operating cash flow at 75.1%. Short-term assets significantly exceed liabilities, indicating strong liquidity management. Despite trading slightly below estimated fair value, analysts expect a potential price increase of 31%. Recent guidance suggests EBIT between A$19.2 million and A$19.8 million for the half-year ending December 2024, signaling continued revenue growth prospects.

ASX:IPG Financial Position Analysis as at Jan 2025
ASX:IPG Financial Position Analysis as at Jan 2025

Impact Minerals (ASX:IPT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Impact Minerals Limited is an Australian exploration company with a market capitalization of A$36.71 million.

Operations: The company generates revenue from its mineral exploration activities, totaling A$0.12 million.

Market Cap: A$36.71M

Impact Minerals Limited, with a market cap of A$36.71 million, is pre-revenue and unprofitable but has secured a A$2.87 million grant for its Lake Hope project to produce High Purity Alumina (HPA), a critical mineral. This initiative involves collaboration with CPC Engineering and Edith Cowan University to develop innovative processes with minimal environmental impact. The company aims to construct a pilot plant in 2025 as part of its research and development efforts, supported by the Federal Government's CRC-P program. Despite shareholder dilution over the past year, Impact remains debt-free with sufficient short-term assets exceeding liabilities.

ASX:IPT Financial Position Analysis as at Jan 2025
ASX:IPT Financial Position Analysis as at Jan 2025

Nanosonics (ASX:NAN)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nanosonics Limited is a global infection prevention company with a market capitalization of A$925.82 million.

Operations: The company generates revenue of A$170.01 million from its healthcare equipment segment.

Market Cap: A$925.82M

Nanosonics Limited, with a market cap of A$925.82 million, generates A$170.01 million in revenue from its healthcare equipment segment. The company maintains a stable weekly volatility of 4%, supported by strong financial health with short-term assets significantly exceeding liabilities and no debt concerns. Despite recent negative earnings growth and declining profit margins from 12% to 7.6%, Nanosonics is trading at 38.7% below estimated fair value, suggesting potential undervaluation. Management and board experience remain robust, although recent board changes may impact strategic direction as key members step down after long tenures. Earnings are forecasted to grow annually by about 23.96%.

ASX:NAN Financial Position Analysis as at Jan 2025
ASX:NAN Financial Position Analysis as at Jan 2025

Key Takeaways

  • Dive into all 1,050 of the ASX Penny Stocks we have identified here.
  • Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
  • Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About ASX:NAN

Nanosonics

Operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.

Flawless balance sheet with solid track record.

Similar Companies

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4346.7% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7838.3% undervalued
25 users have followed this narrative
4 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1753.8% overvalued
4 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6438.5% undervalued
31 users have followed this narrative
3 users have commented on this narrative
13 users have liked this narrative

Updated Narratives

AN
andre_santos
O logo
andre_santos on Realty Income ·

Realty Income - A Fundamental and Historical Valuation

Fair Value:US$73.4610.2% undervalued
28 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HP
MSFT logo
HpN on Microsoft ·

A Structured Counter‑Analysis of "The Leaking Dreadnought"

Fair Value:US$509.8220.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
GOOGL logo
Vestra on Alphabet ·

Alphabet Inc. (GOOG): The Gemini Era – Consolidating AI Dominance in 2026.

Fair Value:US$35514.6% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.888.0% undervalued
65 users have followed this narrative
5 users have commented on this narrative
28 users have liked this narrative
KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.376.7% undervalued
48 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.0% undervalued
1299 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative